Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|November 1, 1998
Supplements and Featured Publications
- Chronic Viral Hepatitis in the Era of Managed Care
- Volume 4
- Issue 12 Suppl
Viral Hepatitis: Impact, Treatment, and Costs
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
An Overview of Viral Hepatitisalmost 28 years ago
New Epidemiologic Data on Hepatitis B and Calmost 28 years ago
Appropriate Screening and Early Diagnosis of Hepatitis B and Calmost 28 years ago
Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis Calmost 28 years ago
State-of-the-Art Interferon Therapy for Chronic Viral Hepatitisalmost 28 years ago
Cost Effectiveness of Treating Chronic Hepatitis B and Calmost 28 years ago
Chronic Hepatitis C: An Overviewalmost 28 years ago
Chronic Hepatitis C: Impact, Diagnosis, and Treatmentalmost 28 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?
2
Zanubrutinib Outlasting Acalabrutinib in CLL
3
FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication
4
Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care
5